Detection of hepatitis C virus among HIV patients in Port Harcourt, Rivers State

Glory Barinuaka Baeka1,2, Julius Kola Oloke1, Oluyinka Oladele Opaleye1,3

  • 1Department of Pure and Applied Biology (Microbiology/Virology Unit), Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria.

African Health Sciences
|February 28, 2022
PubMed

Insights

Hepatitis C virus (HCV) co-infection is prevalent in HIV-infected individuals in Port Harcourt. Routine screening for HCV is recommended for this population, as low CD4+ counts were observed regardless of age or gender.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis C virus (HCV) is a significant global pathogen linked to chronic liver disease.
  • HIV/HCV co-infection presents a heightened risk for adverse health outcomes.

Purpose of the Study:

  • To determine the prevalence of HCV infection among individuals living with HIV in Port Harcourt, Rivers State.
  • To investigate the relationship between HCV infection and CD4+ counts in this population.

Main Methods:

  • A cross-sectional study involving 550 HIV-infected patients (aged 18+) attending an antiretroviral clinic.
  • Data collection included a modified questionnaire, blood sample analysis for HCV antibodies, and retrieval of CD4+ counts from patient files.
  • HCV antibody detection utilized a third-generation commercial kit; statistical analysis was performed using Stata v16.

Main Results:

  • The overall prevalence of HCV antibody positivity was 4.4% (24/550).
  • The highest prevalence (29.2%) was observed in the 31-35 age group.
  • Mean CD4+ count was 303.08±194 cells/µl, with no significant age or gender dependency.

Conclusions:

  • HIV/HCV co-infection is present in the studied population in Port Harcourt.
  • Low CD4+ counts were noted in co-infected individuals, independent of age or gender.
  • Routine HCV screening is advised for all HIV-infected patients.
Abstract